VIVOMERIDIAN BIOSCIENCE INC

Nasdaq meridianbioscience.com


$ 33.97 $ 0.00 (0 %)    

Monday, 30-Jan-2023 15:59:52 EST
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 33.97
$ 33.97 x 900
$ 33.99 x 1,100
-- - --
$ 20.35 - $ 34.38
6,422,835
na
1.49B
$ 0.37
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-09-2023 12-31-2022 10-Q
2 11-22-2022 09-30-2022 10-K
3 08-05-2022 06-30-2022 10-Q
4 05-06-2022 03-31-2022 10-Q
5 02-04-2022 12-31-2021 10-Q
6 11-23-2021 09-30-2021 10-K
7 08-06-2021 06-30-2021 10-Q
8 05-07-2021 03-31-2021 10-Q
9 02-05-2021 12-31-2020 10-Q
10 11-23-2020 09-30-2020 10-K
11 08-07-2020 06-30-2020 10-Q
12 05-08-2020 03-31-2020 10-Q
13 02-07-2020 12-31-2019 10-Q
14 11-26-2019 09-30-2019 10-K
15 08-07-2019 06-30-2019 10-Q
16 05-07-2019 03-31-2019 10-Q
17 02-11-2019 12-31-2018 10-Q
18 11-29-2018 09-30-2018 10-K
19 08-09-2018 06-30-2018 10-Q
20 05-10-2018 03-31-2018 10-Q
21 02-07-2018 12-31-2017 10-Q
22 11-29-2017 09-30-2017 10-K
23 08-09-2017 06-30-2017 10-Q
24 05-10-2017 03-31-2017 10-Q
25 02-09-2017 12-31-2016 10-Q
26 11-29-2016 09-30-2016 10-K
27 08-09-2016 06-30-2016 10-Q
28 05-06-2016 03-31-2016 10-Q
29 02-09-2016 12-31-2015 10-Q
30 11-30-2015 09-30-2015 10-K
31 08-10-2015 06-30-2015 10-Q
32 05-11-2015 03-31-2015 10-Q
33 02-09-2015 12-31-2014 10-Q
34 12-01-2014 09-30-2014 10-K
35 08-11-2014 06-30-2014 10-Q
36 05-12-2014 03-31-2014 10-Q
37 02-10-2014 12-31-2013 10-Q
38 11-29-2013 09-30-2013 10-K
39 08-09-2013 06-30-2013 10-Q
40 05-10-2013 03-31-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

DoubleVerify Holdings Inc. (NYSE:DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P SmallCap 600 effective p...

 meridian-bioscience-q4-eps-020-down-from-023-yoy-sales-6567m-down-from-7620m-yoy

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.20 per share. This is a 13.04 percent decrease over earning...

 meridian-bioscience-as-of-october-11-obtained-merger-approval-for-all-relevant-antitrust-and-fdi-filings-except-for-filing-related-to-committee-on-foreign-investment-in-the-united-states

- Reuters 

 looking-into-meridian-biosciences-return-on-capital-employed

Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro...

 meridian-bioscience-q3-earnings-insights

  Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what i...

 meridian-bioscience-q3-eps-016-inline-sales-6780m-beat-6682m-estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This...

 earnings-scheduled-for-august-5-2022

  Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per shar...

 preview-meridian-biosciences-earnings

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what in...

 meridian-bioscience-receives-re-authorization-from-fda-for-its-revogene-sars-cov-2-molecular-assay

Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materia...

 hc-wainwright--co-downgrades-meridian-bioscience-to-neutral-raises-price-target-to-34

HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the pric...

 cannabis-stock-gainers-and-losers-from-july-6-2022

GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50